Pharmaquinone® is the purest vitamin K2 available on the market, which does not contain the cis isomer according to the US Pharmacopoeia method and is produced by Vitasynth in its own European manufacturing site through a patented manufacturing and purification processes.
Our new manufacturing facility significantly increases our production capacity, ensuring the highest quality standards for our vitamins. This investment allows us to meet growing market demands with greater efficiency and innovation.
Eurofins 102% CoA vs Pharmaquinone 100% API CoA
Our production not only meets but exceeds the quality benchmarks set by the official reference standard, as confirmed through rigorous third-party testing.
Pharmaquinone® is produced using a proprietary EU-patented process (with a US patent pending) that guarantees its distinctive “single peak” purity. We define this as second-generation synthesis.
We purchased a low-cost Vitamin K2 MK-7 from our competitors that is available through various international distributors. We obtained different forms of the product, including both powders and oils with several types of carriers, totaling four batches. We found out it was the most expensive K2 ever.
Vitamin D3 and K2 market is a very lucrative slice of the pie over which the largest players fiercely compete. Unfortunately, analysis of marketplace products shows that not everyone is playing fair.
2006 Vitamin K2 introductory meetings at Vitafoods Geneva between Nattopharma ASA and EuroPharma Alliance
2007 EuroPharma Alliance becomes sole distributor of Nattopharma in Central East Europe
2008 MK-7 synthesis discussions at SupplySide West, Las Vegas between EuroPharma Alliance and Syntavit AS, future Kappa Bioscience AS
2009 VitaSynth (a sister company to EuroPharma Alliance) is incorporated and signs MK-7 synthesis development agreement with an academic partner
2012 VitaSynth files first generation synthesis patent
2013 - 2020
2013 VitaSynth sells the patent to Nattopharma ASA, retains the manufacturing rights
2017 VitaSynth moves commercial production of vitamin K2 to own facility
2020 VitaSynth files second generation synthesis patent
2021 and onwards
2021 Pharmaquione range is launched globally at Vitafoods Geneva
2022 Successful scale up of the key intermediate
2023 Vitasynth gets second generation synthesis patent as the first EU country
Show all
Why consume?
Why would I need K2 in the first place? Calcium is the scaffolding of our body. It is the most abundant metal in our body and it declines as we age. Calcium metobolism is managed by two vitamins: D and K. It doesn't matter if you are a mother of developing children, a performing athlete, premenopausal female or elderly. Your first choice of supplement shall always be: vitamin D3+K2 drops or capsules.
Origin of Ingredients is important for: 63% of brand managers and 81% of adult consumers. Yet, 79% of them say they don't often see this information on product labels.
.png)
.png)
.png)
.png)
